Trial
NCT02083536
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Ovarian Cancer
Intervention
Low Dose Fractionated Whole Abdominal Radiation Therapy
Why stopped
Study voluntarily stopped by Principal Investigator due to lack of accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-10